Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
life sciences
national blog main
new york blog main
new york top stories
san francisco blog main
san francisco top stories
acute migrane
acute myeloid leukemia
alx oncology
artificial intelligence
autoimmune diseases
bain capital
bausch health
berkeley lights
biotech ipos
boston blog main
boston top stories
breast cancer
cancer drugs
cancer immunotherapy
cd47
chronic kidney disease
crosslink capital
deals
deerfield healthcare technology acquisitions
deerfield management company
desmoid tumor
digital health
dihydroergotamine
dihydroergotamine mesylate
eqt
eqt life sciences
europe blog main
europe top stories
fda
fundamentalvr
generic drug
glaxosmithkline
What
hasn’t
5
×
medical
biotech
companies
days
health
help
industry
ipo
ipos
long
new
promise
raised
raises
reality
research
slowed
accelerate
access
accessing
activity
actually
aging
applications
arrival
authorized
businesses
caregiving
circles
data
day
decades
despite
dog
drug
easily
ehr
electronic
far
Language
unset
5
×
Current search:
hasn’t
×
unset
×
@WIRED
1 year ago
The idea that aging might one day be treatable hasn’t yet won over regulators like the FDA, but it has been gaining ground in the field of medical research. 8/9 https://t.co/pkb5sTS9Np
@techcrunch.com
1 year ago
Medical simulation platform FundamentalVR raises $20M to help surgeons learn through VR
@techcrunch.com
3 years ago
Medchart raises $17M to help businesses more easily access patient-authorized health data
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs